Abstract:Two different mechanisms are considered to be the primary cause of aging. Cumulative DNA damage caused by reactive oxygen species (ROS), the by-products of oxidative phosphorylation, is one of these mechanisms (ROS concept). Constitutive stimulation of mitogen- and nutrient-sensing mTOR/S6 signaling is the second mechanism (TOR concept). The flow- and laser scanning- cytometric methods were developed to measure the level of the constitutive DNA damage/ROS- as well as of mTOR/S6- signaling in individual cells. Specifically, persistent activation of ATM and expression of γH2AX in untreated cells appears to report constitutive DNA damage induced by endogenous ROS. The level of phosphorylation of Ser235/236-ribosomal protein (RP), of Ser2448-mTOR and of Ser65-4EBP1, informs on constitutive signaling along the mTOR/S6 pathway. Potential gero-suppressive agents rapamycin, metformin, 2-deoxyglucose, berberine, resveratrol, vitamin D3 and aspirin, all decreased the level of constitutive DNA damage signaling as seen by the reduced expression of γH2AX in proliferating A549, TK6, WI-38 cells and in mitogenically stimulated human lymphocytes. They all also decreased the level of intracellular ROS and mitochondrial trans-membrane potential ΔΨm, the marker of mitochondrial energizing as well as reduced phosphorylation of mTOR, RP-S6 and 4EBP1. The most effective was rapamycin. Although the primary target of each on these agents may be different the data are consistent with the downstream mechanism in which the decline in mTOR/S6K signaling and translation rate is coupled with a decrease in oxidative phosphorylation, (revealed by ΔΨm) that leads to reduction of ROS and oxidative DNA damage. The decreased rate of translation induced by these agents may slow down cells hypertrophy and alleviate other features of cell aging/senescence. Reduction of oxidative DNA damage may lower predisposition to neoplastic transformation which otherwise may result from errors in repair of DNA sites coding for oncogenes or tumor suppressor genes. The data suggest that combined assessment of constitutive γH2AX expression, mitochondrial activity (ROS, ΔΨm) and mTOR signaling provides an adequate gamut of cell responses to evaluate effectiveness of gero-suppressive agents.

Retinoblastoma protein is the likely common effector for distinct anti-aging pathways

Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions.

Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition

Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence.

Planet RB: a personal contribution to a proteomic map of human retinoblastoma protein

Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies

The tumor suppression theory of aging

Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically-diverse nematodes

Cell senescence, rapamycin and hyperfunction theory of aging

Reprogramming Towards Anabolism Impedes Degeneration in a Preclinical Model of Retinitis Pigmentosa.

Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling

With TOR, Less is More: A Key Role for the Conserved Nutrient-Sensing TOR Pathway in Aging

Structural and mechanistic diversity in p53-mediated regulation of organismal longevity across taxonomical orders

Senescence Aging, And Malignant Transformation Mediated By P53 In Mice Lacking The Brcal Full-Length Isoform

Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells

A comprehensive model for the biochemistry of ageing, senescence and longevity

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Living Beyond Restriction: LBR promotes cellular immortalization by suppressing genomic instability and senescence

Inhibition of PAR-1 Delays Aging Via Activating AMPK in C. Elegans.

Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor

Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging